Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ryan Nelson

Executive Editor

Washington, D.C.
Ryan Nelson is managing editor of Informa’s Rose Sheet and the head of its cosmetics content channel, with particular expertise in evolving regulatory and legal issues. He’s been covering FDA-regulated industries for going on 15 years, previously reporting for the Gray Sheet (now Medtech Insight) where he handled beats including Capitol Hill and Emerging Technology. He began his career teaching English Literature to 9th grade boys at a private boarding school in Chattanooga, Tennessee, a role he misses only occasionally. Ryan is based in Informa’s Washington, D.C. office.
Set Alert for Articles By Ryan Nelson

Latest From Ryan Nelson

‘Astonishing Results’ Or ‘Outrageous’ Claims? Peter Thomas Roth Fighting Bicoastal Class Actions

Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.

United States Beauty

Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies

Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.

United States Legal Issues

ECHA Supporting Efforts To Speed Disinfectants To European Market

The European Chemicals Agency is working to develop a centralized, expedited authorization process to increase the availability of disinfectants to consumers and healthcare professionals fighting the novel coronavirus. Meanwhile, the ECHA encourages companies to work with national authorities on single-market applications for derogations under the Biocidal Products Regulation to speed up production.

Europe Beauty

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.

United States Legal Issues

NGOs Are Optimistic About Washington State’s Safer Products Regulation, For Good Reason

California’s Safer Consumer Products regime has been criticized for being too slow to address perceived dangerous chemicals and too reliant on manufacturer-led alternatives analyses. Washington state’s Safer Products program established in 2019 is designed to eliminate those alleged impediments.

US States Legislation

Washington State Exploring Potential Restrictions On Phthalates In Personal-Care Fragrances

The Evergreen State’s California-esque Safer Products for Washington program is looking at phthalates use in the beauty and personal-care sectors as one of its first proposed priority product selections, which could lead to reporting requirements or sales restrictions.

US States Legislation
See All
UsernamePublicRestriction

Register